Spectrum Pharmaceutecals Inc (SPPI)

[antihama]

Here's an Analyst Research article from postanalyst.com on SPPI. More or less agrees w the Yahoo Analysts page on Yahoo but in words. However, a graph can't convey the bullish sentiment as this article somewhat does

Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) last session’s volume of 0.91 million shares was higher than its average volume of 0.72 million shares. The stock, after opening at $6.51, hit $6.19 through the close by scoring -4.62%.
Spectrum Pharmaceuticals, Inc. (SPPI) Analyst Opinion
Spectrum Pharmaceuticals, Inc. has a consensus buy rating from 4 Wall Street analysts, and the number of shares currently sold short amount to at least 9.04% of shares outstanding. The stock sank -1.9% last month and is up 39.73 this year. Wall Street is only getting more bullish on the stock, with 4 of analysts who cover SPPI having a buy-equivalent rating. Analysts have placed a $9.63 price target on Spectrum Pharmaceuticals, Inc., suggesting a 55.57% gain from recent close. It’s currently trading about -20.03% below its 52-week high.
Spectrum Pharmaceuticals, Inc. Earnings Surprise
Spectrum Pharmaceuticals, Inc. (SPPI) surprised the stock market in its last reported earnings when it earned -$0.22 a piece versus the consensus-estimated -$0.27. Its revenue totaled $31.13 million down -6.77% from the previous quarter. Expect decreased revenue in the current quarter as well. As per the consensus estimate, the company’s year-on-year revenue growth is expected to be at -28.2% during the period. Last year, it had about $43.87 million of revenue.
Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Intraday View
This stock (SPPI) is ahead of its 52-week low with 92.83%. Its last month’s stock price volatility remained 3.94% which for the week stands at 4.57%. The share price has moved backward from its 20 days moving average, trading at a distance of -4.25% and stays 5.01% away from its 50 days moving average. Over the last five days, shares have faced -5.93% losses and now is up 16.51% since hitting its 200-day moving average of $4.9. Spectrum Pharmaceuticals, Inc. (SPPI) has made its way to a 12-month decline of -11.57%.